Výsledky vyhledávání - "Bethany Holderread"

Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program

Autor: Grant H. Skrepnek, Shellie L. Keast, Bethany Holderread, Terry Cothran

Publikováno v: Journal of managed carespecialty pharmacy. 25(11)

Newer hepatitis C virus (HCV) treatments often provide high success rates with fewer adverse events, although the extent of all potential drug interactions is not fully known.To assess outcomes of receiving HCV treatment and subsequent sustained viro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414b900c4407e8a042f00c34c74f9137
https://pubmed.ncbi.nlm.nih.gov/31663456

Zobrazit plný text záznamu

Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid

Autor: Timothy T. Pham, R. Chris Rathbun, David M. Thompson, Grant H. Skrepnek, Kevin C. Farmer, Nancy Nesser, Shellie L. Keast, Bethany Holderread

Publikováno v: Journal of managed carespecialty pharmacy. 24(7)

Outcomes involving newer direct-acting antiviral (DAA) hepatitis C virus (HCV) regimens have not been studied extensively among the Medicaid population.To assess clinical (treatment failure) and economic outcomes for chronic HCV-infected Oklahoma Med

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::784f35f60432b5622f8969dd25642e73
https://pubmed.ncbi.nlm.nih.gov/29952711

Zobrazit plný text záznamu

The pharmacist's role in shaping the future of value-based payment models in state Medicaid programs

Autor: Terry Cothran, Melissa Abbott, Shellie L. Keast, Bethany Holderread, Nancy Nesser

Publikováno v: Journal of the American Pharmacists Association : JAPhA. 59(1)

Objectives To describe roles for pharmacists to facilitate payer-initiated value-based contracts within state Medicaid programs. Summary According to the Centers for Medicare and Medicaid Services, prescription drug expenditures are expected to see t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665f88f85edb8ff8afad01620c88ad64
https://pubmed.ncbi.nlm.nih.gov/30528252

Zobrazit plný text záznamu

Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost

Autor: Grant H. Skrepnek, Shellie L. Keast, Bethany Holderread, Terry Cothran

Publikováno v: Journal of the American Pharmacists Association : JAPhA. 58(5)

The market for chronic hepatitis C (HCV) treatment has changed rapidly. New treatments offer high cure rates, fewer adverse effects, and shorter treatments-but also increased costs per therapy. The objective of this study was to compare adherence and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ef179e8aff001fb8819c449ea8332ef
https://pubmed.ncbi.nlm.nih.gov/30033127

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání